 | Volunteers Needed to Test Osteoporosis Medication
St. Louis, Jan. 9, 2003 — Washington University School of Medicine in St. Louis is seeking healthy women to participate in a two-year clinical research study of an investigational osteoporosis medication.
Osteoporosis affects approximately 8 million American women, half of whom suffer an osteoporosis-related fracture at some point. Osteoporosis is referred to as a “silent threat” and often is only diagnosed after a woman suffers a painful bone fracture or other debilitating event.
The School of Medicine is one of 16 sites around the country participating in this study to evaluate the effectiveness of two different treatment administrations for a new osteoporosis medication.
Free osteoporosis screenings are available to all interested women age 55-80 who have been menopausal for at least five years, have not taken hormone replacement therapy since May, are able to carry out daily tasks and do not have any medical conditions that limit participation in a two-year study. Screening is done with a painless procedure that measures bone mineral density, or bone thickness.
Eligible women who join the study will be treated with an active medication for osteoporosis and with daily vitamin D and calcium supplements. Physicians will monitor the effectiveness of the treatment regimen during regular office visits. All treatments and evaluations are free of charge.
For more information, please contact Chris Baldus at (314) 454-8023 or toll-free at (800) 764-1633.
###
The full-time and volunteer faculty of Washington University School of Medicine are the physicians and surgeons of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient-care institutions in the nation. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
|